CARLSBAD, Calif., Nov. 24 /PRNewswire-FirstCall/ -- Visage Imaging(R),
Inc., a wholly owned subsidiary of Mercury Computer Systems, Inc.
(NASDAQ: MRCY), announced it has signed a comprehensive marketing agreement
with Viatronix(R), Inc., a leading developer of 2D/3D medical imaging and
diagnostic software. Under the agreement, Visage Imaging will act as a
representative for Viatronix's V3D-Colon(R) Virtual Colonoscopy product in the
United States. The agreement expands Viatronix's domestic marketing arm, while
extending Visage Imaging's applications portfolio for advanced visualization
products.
"We are extremely excited to be working with Viatronix," said Jim
Schumacher, Vice President and Chief Operating Officer of Visage Imaging.
"Virtual Colonoscopy is becoming a requirement within our customer base, and
the planned, seamless integration of V3D-Colon with our Visage CS platform is
the solution. We are proud to team up with a true market leader in providing
this critical technology."
"We are delighted to enter into this agreement, and believe the integrated
solution harnesses the power of both products to deliver maximum benefit to
the end user," said Zaffar Hayat, CEO and President of Viatronix. "The timing
could not be better because the demand for Virtual Colonoscopy is growing
rapidly in the U.S."
For more information on Visage Imaging's comprehensive line of clinical
products, visit Visage Imaging at RSNA 2008 in Booth #7139 in the North
Building of McCormick Place, Chicago, Illinois, November 30 to December 5;
visit www.visageimaging.com; or contact Visage Imaging at
info@visageimaging.com or +1 888-3D-VISAGE.
Viatronix - Seeing Is Believing(TM)
Viatronix is a leading innovator and developer of 2D/3D medical imaging
and diagnostic software. The software enables physicians to interactively view
vital organs and anatomical structures within the human body from data
acquired by standard medical imaging equipment in minimally or non-invasive
methods.
Viatronix, through application of the V3D(R) technology, is developing
additional innovative products that will be useful in early detection of other
diseases, treatment planning, intervention, and follow-up evaluation.
Viatronix, Inc. is located in Stony Brook, NY. To learn more, call us toll
free at 1-866-887-4636, log on to www.viatronix.com, or visit us at RSNA 2008
in Chicago's McCormick Place, Booth #1518 (Hall D) in the East Building,
November 30 - December 5, 2008.
Visage Imaging, Inc. - Visioneering Science for Life(R)
Visage Imaging, Inc. (www.visageimaging.com) designs and engineers
clinical products that present its customers with the ability to overcome
demanding market challenges and improve diagnostic results with accuracy and
expedience. As a wholly owned subsidiary of Mercury Computer Systems, Inc.,
Visage Imaging incorporates Mercury's 20+ years of technical expertise and
deep knowledge of the science behind diagnostic applications into its
practice, and leverages this experience to push the boundaries of what is
possible within its domain.
Through collaborative learning, Visage Imaging has built a nimble,
creative organization: one that is first to market with innovative 3D
clinical applications, offers best-in-class 3D products that are unique and
reliable, and helps its customers to accelerate their own market innovation
and clinical benefit.
Forward-Looking Safe Harbor Statement
This press release contains certain forward-looking statements, as that
term is defined in the Private Securities Litigation Reform Act of 1995,
including those relating to the Viatronix V3D-Colon Virtual Colonoscopy
product. You can identify these statements by our use of the words "may,"
"will," "should," "plans," "expects," "anticipates," "continue," "estimate,"
"project," "intend," and similar expressions. These forward-looking statements
involve risks and uncertainties that could cause actual results to differ
materially from those projected or anticipated. Such risks and uncertainties
include, but are not limited to, general economic and business conditions,
including unforeseen weakness in Visage Imaging's markets, effects of
continued geopolitical unrest and regional conflicts, competition, changes in
technology and methods of marketing, delays in completing engineering and
manufacturing programs, changes in customer order patterns, changes in product
mix, continued success in technological advances and delivering technological
innovations, continued funding of defense programs, the timing of such
funding, changes in the U.S. Government's interpretation of federal
procurement rules and regulations, market acceptance of Visage Imaging's
products, shortages in components, production delays due to performance
quality issues with outsourced components, inability to fully realize the
expected benefits from acquisitions or delays in realizing such benefits,
challenges in integrating acquired businesses and achieving anticipated
synergies, and difficulties in retaining key customers. These risks and
uncertainties also include such additional risk factors as are discussed in
Mercury Computer Systems, Inc.'s recent filings with the U.S. Securities and
Exchange Commission, including its Annual Report on Form 10-K for the fiscal
year ended June 30, 2008. Visage Imaging cautions readers not to place undue
reliance upon any such forward-looking statements, which speak only as of the
date made. Visage Imaging undertakes no obligation to update any
forward-looking statement to reflect events or circumstances after the date on
which such statement is made.
Contacts:
Diane M Clifford, Director Global Marketing
Visage Imaging, Inc.
Phone: 978-967-1168
E-mail: dclifford@visageimaging.com
Susan Levin
Viatronix, Inc.
Phone: (631) 444-6181
Fax: (631) 444-9701
E-mail: slevin@viatronix.com
Kathleen Sniezek, Corporate Public Relations Manager
Mercury Computer Systems, Inc.
Phone: 978-967-1126
E-mail: ksniezek@mc.com
Visage, Visage Imaging, and Visioneering Science for Life are registered
trademarks of Mercury Computer Systems, Inc. Other product and company names
mentioned may be trademarks and/or registered trademarks of their respective
holders
